English
Italiano
Marco Polo Advisor assists Comecer in the capital increase transaction with the Italian Investment Fund ("Fondo Italiano di Investimento")
The Italian Investment Fund, a private equity vehicle created at the initiative of the Treasury, closed on March 24, 2011 his second transaction, the first in 2011, investing in the sector of nuclear medicine equipments. The Fund has reached an agreement for the entry with a minority stake in Comecer, Castel Bolognese, a company with a turnover of 32 million. The operation involves an equity investment of EUR 7.5 million, achieved through a dedicated capital increase.
Marco Polo Comecer Advisor has assisted in all phases of the operation: the first contact with the fund, the business plan development, the negotiation of the transaction. The capital increase put Comecer in a position to vigorously pursue its growth plan, and to increase its presence on international markets, both per internal and external lines, and with acquisitions of other companies in the sector .
Comecer, which employs 180 employees, started as a technology provider for the nuclear agency and then developled as the Italian company for the automatic management of radio-pharmaceuticals and shielded cells for the nuclear medicine industry. The Fund is promoted by CD, Intesa Sanpaolo, Unicredit, Mps and six other major italian financial institutions.
"The investment in Comecer - says the CEO of the SME Fund Gabriele Cappellini - fits in our strategy to support the growth of technologically advanced companies born from the genius' Italian who can continue to grow with the support of national financial institutions ".
"It 'a strategic move for the growth of Comecer on international markets," says Alessia Zanelli CEO of the company. The company, is the international market leader in management, formulation, dosage systems for radio-pharmaceuticals with products marketed in over 100 countries through a network of direct sales and partnerships with equipment manufacturers of nuclear medicine.
For information contact f.rozzanigo@marcopoloadvisor.it
The Italian Investment Fund, a private equity vehicle created at the initiative of the Treasury, closed on March 24, 2011 his second transaction, the first in 2011, investing in the sector of nuclear medicine equipments. The Fund has reached an agreement for the entry with a minority stake in Comecer, Castel Bolognese, a company with a turnover of 32 million. The operation involves an equity investment of EUR 7.5 million, achieved through a dedicated capital increase.
Marco Polo Comecer Advisor has assisted in all phases of the operation: the first contact with the fund, the business plan development, the negotiation of the transaction. The capital increase put Comecer in a position to vigorously pursue its growth plan, and to increase its presence on international markets, both per internal and external lines, and with acquisitions of other companies in the sector .
Comecer, which employs 180 employees, started as a technology provider for the nuclear agency and then developled as the Italian company for the automatic management of radio-pharmaceuticals and shielded cells for the nuclear medicine industry. The Fund is promoted by CD, Intesa Sanpaolo, Unicredit, Mps and six other major italian financial institutions.
"The investment in Comecer - says the CEO of the SME Fund Gabriele Cappellini - fits in our strategy to support the growth of technologically advanced companies born from the genius' Italian who can continue to grow with the support of national financial institutions ".
"It 'a strategic move for the growth of Comecer on international markets," says Alessia Zanelli CEO of the company. The company, is the international market leader in management, formulation, dosage systems for radio-pharmaceuticals with products marketed in over 100 countries through a network of direct sales and partnerships with equipment manufacturers of nuclear medicine.
For information contact f.rozzanigo@marcopoloadvisor.it